now browsing by month
Arthritis pain sufferers are finding that broad spectrum CBC reduces the aching and inflammation that accompanies osteoarthritis. Chinese herbalists began recommending cannabis for arthritis pain over 4000 years ago. In the last 40 years, laboratory scientists have tested the ability of the marijuana plant to treat osteoarthritis. A series of research studies beginning in 1974 have shown that endocannabinoids decrease inflammation, a major contributor to arthritis pain.
Cannabichromene (CBC) is derived from the cannabis plant, but unlike THC, CBC does not make patients high. Inflammation is one of the body’s weapons to remove pathogens or repair damaged tissue. However, inflammation that lasts several days (or weeks) can lead to autoimmune responses. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often recommended for arthritic pain and swelling, but many patients experience side effects. The most common side effects of NSAIDs are bloating, stomach pain, and nausea.
Plant-based CBC works differently than NSAIDs like Advil or Aleve. Broad spectrum CBC attacks inflammation by activating the receptors in the brain that perceive pain. By binding with these receptors, CBC triggers an increase in endocannabinoids. These endocannabinoids work at the cellular level to limit the inflammation response to only the amount needed to solve the problem. So your body gets the benefits of inflammation without the long-term risk of developing autoimmune disorders. The result: reduced swelling and less pain.